Structural brain changes in patients with chronic obstructive pulmonary disease (COPD)

R. W. Esser, M. C. Stoeckel, A. Kirsten, H. Watz, K. Lehmann, K. Taube, H. Magnussen, C. Büchel, A. von Leupoldt (Hamburg, Grosshansdorf, Germany; Leuven, Belgium)

Source: International Congress 2014 – COPD and PAH related imaging
Session: COPD and PAH related imaging
Session type: Thematic Poster Session
Number: 646
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. W. Esser, M. C. Stoeckel, A. Kirsten, H. Watz, K. Lehmann, K. Taube, H. Magnussen, C. Büchel, A. von Leupoldt (Hamburg, Grosshansdorf, Germany; Leuven, Belgium). Structural brain changes in patients with chronic obstructive pulmonary disease (COPD). Eur Respir J 2014; 44: Suppl. 58, 646

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

Effect of obstructive lung disease on mosaic attenuation patern in CTEPH patient
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013

The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014


Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance
Year: 2015

Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Quantitative CT characterisation of stable COPD patients relates to COPD severity and exacerbation frequency
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006


Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Local and systemic inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013


Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Quantitative computed tomography (QCT) measured 5th generation airways, emphysema and airflow obstruction in chronic obstructive pulmonary disease (COPD) from a COPDMAP cohort
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014

Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013


Histological correlates of vascular density analysis by computer tomography in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013

Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009



The dynamic lung volume analysis in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 212s
Year: 2005

Functional and inflammatory bowel diseases in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Survivin in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015

Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
Source: International Congress 2014 – Markers
Year: 2014

Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016